CHEMILOGICAL
Dead / Abandoned — Abandoned — failure to respond (as of 05 Oct 2023)
What this means for you
This application is over — abandoned 22 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97576955
- Mark type
- Stylized text
- Filed
- 02 Sept 2022
- Abandoned
- 22 Sept 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development
Owner
- Empress Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 05 Oct 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 05 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 05 Oct 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jun 2023 — NON-FINAL ACTION E-MAILED
- 21 Jun 2023 — NON-FINAL ACTION WRITTEN
- 20 Jun 2023 — ASSIGNED TO EXAMINER
- 21 Sept 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED